News + Filings Transactions
|
HEALY JAMES
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/30/2023 | Natera, Inc. | NTRA | Grant | Common Stock | 2.8k | $0.00 | $0 | | 06/30/2023 |
| 06/30/2023 | Natera, Inc. | NTRA | Grant | Stock Option (right to buy) | 4.3k | $48.66 | $207k | | 06/30/2023 |
| 06/08/2023 | Y-mAbs Therapeutics, Inc. | YMAB | Grant | | 14k | $8.13 | $113.4k | | 06/08/2023 |
| 06/08/2023 | Y-mAbs Therapeutics, Inc. | YMAB | Grant | Common Stock | 2.3k | $0.00 | $0 | | 06/08/2023 |
| 05/25/2023 | Natera, Inc. | NTRA | Exercise | Restricted Stock Unit | 3.5k | $0.00 | $0 | | 05/25/2023 |
| 02/24/2023 | CinCor Pharma, Inc. | | Other | Common Stock | 9.8k | $0.00 | $0 | | 11/28/2022 |
| 02/24/2023 | CinCor Pharma, Inc. | | Disposition | Common Stock | 19.6k | $0.00 | $0 | | 11/28/2022 |
| 02/24/2023 | CinCor Pharma, Inc. | | Other | Common Stock | 6.1M | $0.00 | $0 | By Sofinnova Venture Partners X, L.P. | 11/28/2022 |
| 01/13/2023 | Natera, Inc. | NTRA | Grant | Common Stock | 390 | $40.01 | $15.6k | | 01/13/2023 |
| 11/28/2022 | CinCor Pharma, Inc. | | Sale | Common Stock | 6k | $14.32 | $85.9k | By Sofinnova Synergy Master Fund, LP | 11/28/2022 |
| 08/11/2022 | CinCor Pharma, Inc. | | Purchase | Common Stock | 500k | $30.00 | $15M | By Sofinnova Venture Partners X, L.P. | 08/11/2022 |
| 08/11/2022 | CinCor Pharma, Inc. | | Purchase | Common Stock | 6k | $30.00 | $180k | By Sofinnova Synergy Master Fund, LP | 08/11/2022 |
| 08/05/2022 | Karuna Therapeutics, Inc. | KRTX | Exercise | Option (right to buy) | 32.5k | $16.00 | $520k | | 08/05/2022 |
| 08/05/2022 | CinCor Pharma, Inc. | | Exercise | Stock Option (Right to Buy) | 29.4k | $13.60 | $400k | | 08/05/2022 |
| 07/15/2022 | Y-mAbs Therapeutics, Inc. | YMAB | Grant | | 16k | $16.64 | $266.2k | | 07/15/2022 |
| 07/08/2022 | Natera, Inc. | NTRA | Grant | Common Stock | 430 | $0.00 | $0 | | 07/08/2022 |
| 07/08/2022 | Natera, Inc. | NTRA | Grant | Restricted Stock Unit | 430 | $36.31 | $15.6k | | 07/08/2022 |
| 06/30/2022 | Karuna Therapeutics, Inc. | KRTX | Purchase | Common Stock | 48.1k | $122.27 | $5.9M | By Sofinnova Venture Partners X, LP | 06/29/2022 |
| 06/30/2022 | Karuna Therapeutics, Inc. | KRTX | Purchase | Common Stock | 24.2k | $123.39 | $3M | By Sofinnova Venture Partners X, LP | 06/29/2022 |
| 06/29/2022 | Karuna Therapeutics, Inc. | KRTX | Purchase | Common Stock | 6.8k | $124.73 | $852.2k | By Sofinnova Venture Partners X, LP | 06/29/2022 |
| 06/29/2022 | Karuna Therapeutics, Inc. | KRTX | Purchase | Common Stock | 9.1k | $125.00 | $1.1M | By Sofinnova Venture Partners X, LP | 06/29/2022 |
| 06/29/2022 | Karuna Therapeutics, Inc. | KRTX | Purchase | Common Stock | 27.8k | $121.99 | $3.4M | By Sofinnova Venture Partners X, LP | 06/29/2022 |
| 06/29/2022 | Karuna Therapeutics, Inc. | KRTX | Purchase | Common Stock | 4k | $122.95 | $496.6k | By Sofinnova Venture Partners X, LP | 06/29/2022 |
| 06/15/2022 | Karuna Therapeutics, Inc. | KRTX | Grant | Option (right to buy) | 5k | $102.96 | $514.8k | | 06/15/2022 |
| 06/10/2022 | Bolt Biotherapeutics, Inc. | BOLT | Grant | Stock Option (Right to Buy) | 25k | $1.99 | $49.8k | | 06/10/2022 |
| 05/27/2022 | Natera, Inc. | NTRA | Grant | Stock Option (right to buy) | 7.1k | $41.19 | $291.1k | | 05/27/2022 |
| 05/27/2022 | Natera, Inc. | NTRA | Grant | Restricted Stock Unit | 3.5k | $0.00 | $0 | | 05/27/2022 |
| 05/25/2022 | Natera, Inc. | NTRA | Exercise | Restricted Stock Unit | 1.3k | $0.00 | $0 | | 05/25/2022 |
| 04/01/2022 | Karuna Therapeutics, Inc. | KRTX | Purchase | Common Stock | 47 | $129.38 | $6.1k | By Sofinnova Synergy Master Fund, LP | 04/01/2022 |
| 03/24/2022 | Bolt Biotherapeutics, Inc. | BOLT | Grant | Stock Option (Right to Buy) | 25k | $3.03 | $75.8k | | 03/24/2022 |
| 01/11/2022 | CinCor Pharma, Inc. | | Conversion | Common Stock | 5.2M | $0.00 | $0 | By Sofinnova Venture Partners X, L.P. | 01/11/2022 |
| 01/11/2022 | CinCor Pharma, Inc. | | Purchase | Common Stock | 325k | $16.00 | $5.2M | By Sofinnova Venture Partners X, L.P. | 01/11/2022 |
| 01/11/2022 | CinCor Pharma, Inc. | | Conversion | Series A Preferred Stock | 13.6M | $0.00 | $0 | By Sofinnova Venture Partners X, L.P. | 01/11/2022 |
| 01/11/2022 | CinCor Pharma, Inc. | | Conversion | Series B Preferred Stock | 4.3M | $0.00 | $0 | By Sofinnova Venture Partners X, L.P. | 01/11/2022 |
| 01/07/2022 | Coherus BioSciences, Inc. | CHRS | Grant | Stock Option (Right to Buy) | 27k | $15.94 | $430.4k | | 01/07/2022 |
|
|